11 reports of this reaction
2.5% of all POTASSIUM NITRATE reports
#7 most reported adverse reaction
ORAL MUCOSAL EXFOLIATION is the #7 most commonly reported adverse reaction for POTASSIUM NITRATE. There are 11 FDA adverse event reports linking POTASSIUM NITRATE to ORAL MUCOSAL EXFOLIATION. This represents approximately 2.5% of all 437 adverse event reports for this drug.
Patients taking POTASSIUM NITRATE who experience oral mucosal exfoliation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ORAL MUCOSAL EXFOLIATION is a less commonly reported adverse event for POTASSIUM NITRATE, but still significant enough to appear in the safety profile.
In addition to oral mucosal exfoliation, the following adverse reactions have been reported for POTASSIUM NITRATE:
The following drugs have also been linked to oral mucosal exfoliation in FDA adverse event reports:
ORAL MUCOSAL EXFOLIATION has been reported as an adverse event in 11 FDA reports for POTASSIUM NITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ORAL MUCOSAL EXFOLIATION accounts for approximately 2.5% of all adverse event reports for POTASSIUM NITRATE, making it a notable side effect.
If you experience oral mucosal exfoliation while taking POTASSIUM NITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.